Kimberly Ann Chapman, M.D.
NPI 1194915306ActiveIndividual· Medical Genetics, Clinical Biochemical Genetics· Los Angeles, CA
Medical Genetics, Clinical Biochemical Genetics (M.D.) in Los Angeles, California, trained at University of Nevada School of Medicine (class of 2002). Part D covered 16 prescriptions written in 2024, 100% of them generic. Travere Therapeutics, Inc. was the largest of 3 companies reporting payments in 2025, $3,634 in all, mostly consulting fees.
Overview
| NPI | 1194915306 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | M.D. |
| Sole proprietor | No |
| NPI issued | Jul 25, 2007 |
| Last updated in NPPES | Aug 7, 2026 |
| Certified by provider | Aug 7, 2026 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Medical Genetics, Clinical Biochemical Genetics Primary | 207SG0202X | C199800 | CA |
| Medical Genetics, Clinical Biochemical Genetics | 207SG0202X | 0101247572 | VA |
| Medical Genetics, Clinical Genetics (M.D.) | 207SG0201X | MD424385 | PA |
| Medical Genetics, Clinical Biochemical Genetics | 207SG0202X | D0070778 | MD |
| Medical Genetics, Clinical Genetics (M.D.) | 207SG0201X | D0070778 | MD |
| Medical Genetics, Clinical Biochemical Genetics | 207SG0202X | MD0838730 | DC |
| Medical Genetics, Clinical Genetics (M.D.) | 207SG0201X | MD0838730 | DC |
| Medical Genetics, Clinical Genetics (M.D.) | 207SG0201X | 0101247572 | VA |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Nov 10, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 11, 2026 | No match | — |
| New York OMIG · Nov 11, 2026 | No match | — |
| Ohio Medicaid · Nov 11, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 11, 2026 | No match | — |
| Washington HCA · Nov 11, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Pediatric Medicine (CA); Practitioner - Pediatric Medicine (DC) |
|---|
Part D prescriptions in 2024
| Prescriptions (claims) | 16 · 30 30-day fills |
|---|---|
| Total drug cost | $4,339 |
| Generic share | 100% of claims |
Education and affiliations
| Medical school | University of Nevada School of Medicine |
|---|---|
| Graduation year | 2002 |
| Medicare specialty | Pediatric Medicine |
Medical group
- Childrens Hospital Los Angeles Medical Group IncLos Angeles, CA · 295 clinicians
Industry payments (Open Payments)
- 2025$3,634 · 4 payments from 3 companies
- 2024$85.40 · 2 payments from 2 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Travere Therapeutics, Inc. | $3,574 | 2 |
| Ptc Therapeutics, Inc. | $38.14 | 1 |
| Medunik USA Inc. | $21.37 | 1 |
What the 2025 payments were for
- Consulting Fee$3,500 · 1 payment
- Food and Beverage$133.94 · 3 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other Medical Genetics, Clinical Biochemical Genetics providers in Los Angeles
- 1154515963
All Medical Genetics, Clinical Biochemical Genetics providers in California